Is Plerixafor Injection in shortage?
Plerixafor Injection is listed by FDA as being discontinued by at least one maker (updated Mar 13, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Plerixafor, Injection, 24 mg per 1.2 mL (20 mg per mL) (NDC 65219-284-12)
A business decision was made to discontinue manufacture of the drug.
Maker contact: 888-391-6300 www.fresenius-kabi.com
FDA recalls of Plerixafor
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Plerixafor Injection:
- Sanofi-Aventis U.S. LLC recalls Mozobil (plerixafor injection) 24mg/1.2mL (20mg/mL), For Single Use Only, Rx Only, Manufactured by: Genzyme Corporation
- Genzyme Corporation / Genzyme Biosurgery recalls Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured
Plerixafor Injection shortage questions
Is Plerixafor Injection in shortage?
Plerixafor Injection is listed by FDA as being discontinued by at least one maker (updated Mar 13, 2026).
What should I do if I can’t get Plerixafor Injection?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.